Gossamer Bio is a biopharmaceutical company focused on discovering, developing, and commercializing immunology-based therapeutics in the autoimmune, allergy/inflammation, immuno-oncology and fibrosis disease areas to improve the lives of patients.
Phase 2 clinical program*
Phase 2 additional indication(s) planned*
Phase 1 clinical program*
First-in-class, HIF-1α stabilizer, for the treatment of inflammatory bowel diseases
Phase 1 clinical program